https://www.theverge.com/2021/8/4/22609212/hbo-max-podcast-exclusive-batman-audio-jeffrey-wright
INmune Bio, Inc. Announces Biomarker Data Demonstrating that the First Patient Treated with its NK Cell Priming “Pseudokine”, INKmune™, Successfully Produced Memory-Like NK Cells
INmune Bio, Inc. (NASDAQ:INMB) (the, “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, announced today
